Private Advisor Group, LLC 13D and 13G filings for Lumos Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-13 4:16 pm Sale |
2024-12-31 | 13G | Lumos Pharma, Inc. LUMO |
Private Advisor Group, LLC | 0 0.000% |
-744,513![]() (Position Closed) |
Filing |
2024-11-12 6:27 pm Purchase |
2024-09-30 | 13G | Lumos Pharma, Inc. LUMO |
Private Advisor Group, LLC | 744,513 9.160% |
744,513![]() (New Position) |
Filing |